Drug recall · October 25, 2017
Alprazolam Tablets recall
Why: Failed Impurities/Degradation Specifications: Out-of-specification result for an unknown impurity.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Alprazolam Tablets, USP, 0.25 mg, 100-count Unit Dose tablets per carton, Rx Only, Manufactured by: Watson Pharma Private Limited, Verna, Salcette Goa 403 722 INDIA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152, NDC 0904-5858-61.
- Lots / codes
Lot 1274C151A, Exp 10/17
- Quantity
- 3,935 cartons
- Company
- The Harvard Drug Group, Livonia, MI
- Distribution
- Nationwide in the USA
- Initiated
- September 26, 2017 · Voluntary: Firm initiated
- Classified
- October 19, 2017
- Reported
- October 25, 2017
- Ended
- April 29, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Alprazolam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.